Castleman's Disease: A Study of a Rare Lymphoproliferative Disorder in a University Hospital

Castleman's disease (CD) is a group of rare lymphoproliferative disorders sharing characteristic clinical and histological features, and usually accompanied by a marked systemic inflammatory response. Three histological patterns of lymph nodes were described: the hyaline-vascular, the plasma-ce...

Full description

Bibliographic Details
Main Authors: Ibrahiem Saeed Abdul-Rahman, Ali M. Al-Amri, Khalid Qassim Ghallab
Format: Article
Language:English
Published: SAGE Publishing 2009-01-01
Series:Clinical Medicine Insights: Blood Disorders
Online Access:https://doi.org/10.4137/CMBD.S2161
id doaj-2490340336a4416b8d46305e9ffab3cc
record_format Article
spelling doaj-2490340336a4416b8d46305e9ffab3cc2020-11-25T01:23:55ZengSAGE PublishingClinical Medicine Insights: Blood Disorders1179-545X2009-01-01210.4137/CMBD.S2161Castleman's Disease: A Study of a Rare Lymphoproliferative Disorder in a University HospitalIbrahiem Saeed Abdul-Rahman0Ali M. Al-Amri1Khalid Qassim Ghallab2Internal Medicine/Nephrology.Internal Medicine/Oncology.Department of Pathology, King Fahd hospital of the University, King Faisal University, saudi Arabia.Castleman's disease (CD) is a group of rare lymphoproliferative disorders sharing characteristic clinical and histological features, and usually accompanied by a marked systemic inflammatory response. Three histological patterns of lymph nodes were described: the hyaline-vascular, the plasma-cell and the mixed types. The former is more common (80%-90%) and tends to be localized. The plasma cell type is more aggressive and usually multicentric. It is interesting that the inflammatory manifestations seem to be related to a lymph node lesion, because the systemic symptoms and inflammatory activity can return to normal after surgical excision or successful medical treatment of the disease. We report here our 15-year experience with this rare disease in King Fahd Hospital of the University, Al-Khobar, Saudi Arabia , focusing on the clinical features, therapy, and patients'outcome.https://doi.org/10.4137/CMBD.S2161
collection DOAJ
language English
format Article
sources DOAJ
author Ibrahiem Saeed Abdul-Rahman
Ali M. Al-Amri
Khalid Qassim Ghallab
spellingShingle Ibrahiem Saeed Abdul-Rahman
Ali M. Al-Amri
Khalid Qassim Ghallab
Castleman's Disease: A Study of a Rare Lymphoproliferative Disorder in a University Hospital
Clinical Medicine Insights: Blood Disorders
author_facet Ibrahiem Saeed Abdul-Rahman
Ali M. Al-Amri
Khalid Qassim Ghallab
author_sort Ibrahiem Saeed Abdul-Rahman
title Castleman's Disease: A Study of a Rare Lymphoproliferative Disorder in a University Hospital
title_short Castleman's Disease: A Study of a Rare Lymphoproliferative Disorder in a University Hospital
title_full Castleman's Disease: A Study of a Rare Lymphoproliferative Disorder in a University Hospital
title_fullStr Castleman's Disease: A Study of a Rare Lymphoproliferative Disorder in a University Hospital
title_full_unstemmed Castleman's Disease: A Study of a Rare Lymphoproliferative Disorder in a University Hospital
title_sort castleman's disease: a study of a rare lymphoproliferative disorder in a university hospital
publisher SAGE Publishing
series Clinical Medicine Insights: Blood Disorders
issn 1179-545X
publishDate 2009-01-01
description Castleman's disease (CD) is a group of rare lymphoproliferative disorders sharing characteristic clinical and histological features, and usually accompanied by a marked systemic inflammatory response. Three histological patterns of lymph nodes were described: the hyaline-vascular, the plasma-cell and the mixed types. The former is more common (80%-90%) and tends to be localized. The plasma cell type is more aggressive and usually multicentric. It is interesting that the inflammatory manifestations seem to be related to a lymph node lesion, because the systemic symptoms and inflammatory activity can return to normal after surgical excision or successful medical treatment of the disease. We report here our 15-year experience with this rare disease in King Fahd Hospital of the University, Al-Khobar, Saudi Arabia , focusing on the clinical features, therapy, and patients'outcome.
url https://doi.org/10.4137/CMBD.S2161
work_keys_str_mv AT ibrahiemsaeedabdulrahman castlemansdiseaseastudyofararelymphoproliferativedisorderinauniversityhospital
AT alimalamri castlemansdiseaseastudyofararelymphoproliferativedisorderinauniversityhospital
AT khalidqassimghallab castlemansdiseaseastudyofararelymphoproliferativedisorderinauniversityhospital
_version_ 1725119978616651776